#Rheumatoid arthritis- is it all or partially in your genes 🧬? Many genes are not sufficient or necessary to produce #RA. Genes were used in a study to predict development of RA better than clinical parameters. But not ready for prime time YET #RNL2022 @RheumNow @karen_kc123 https://t.co/J5aBs4iLbR

Dr. Elena Myasoedova on Multimorbidities and RA Important to recognize multimorbities are 2-3x higher in RA and how it impacts our RA pts @RheumNow #RNL2022 https://t.co/N6VPdU6wzV

Cool idea 💡 for #treatment of #multimorbidity in #rheumatoid arthritis from an interactive web platform #RNL2022 ⁦@RheumNow⁩ https://t.co/QlTWCV8s9F

Role of cytokines in pain ?! Notice CNS activity disappeared immediately before TJC/SJC improvement!! @Tuhina_Neogi @RheumNow #RNL2022 https://t.co/TXKZwepBTF

@Janetbirdope on drug cycling vs. switching in RA Interesting data showing switching to non-TNFi superior to cycling in TNFi-incomplete responders Most bDMARDs and JAKi have blunted response post-TNFi @RheumNow #RNL2022 https://t.co/Lb3wvHZdzN

@Janetbirdope shares her study on real world retention of JAKi vs biologics in #RA #RNL2022 @rheumnow https://t.co/hNxQ8t4LHH

Retention of JAKinibs longer than bDAMRDs in RA Interesting but wonder how this will be affected given new FDA warnings. @RheumNow #RNL2022 https://t.co/Gj2wBFbaAj

Emerging pain targets! Will start prescribing topical Capsaicin more !! Amazing talk by @Tuhina_Neogi @RheumNow #RNL2022 https://t.co/DjAtTjfGCo

#ClinicalPearl #multimorbidity worsens outcomes in #rheumatoid arthritis. 50% of #RA pts has this and 2x > than age sex matched pop’n. Worse as interplay of diseases, drug disposition, med adherence, drug interactions, etc #RNL2022 ⁦@RheumNow⁩ Elena Myasoedova https://t.co/aTF0O8o0tg

Dr. Elena Myasoedova defines multimorbidity and its difference for comorbidities. Multimorbidity (MM) focuses on the patient, comorbidities focuses on the disease. RA pts have 2.3 X higher MM and can precede RA. #RNL2022 @rheumnow https://t.co/FE489rJnnP

Dr Elena Myasedova lectures on the problem of multimorbidity in #RA.#RNL2022 https://t.co/Ti5PZaAx2Z

#RNL2022 Psoriatic Disease for Rheumatologists with Drs. Gordon and Merida. https://t.co/PEj0dI7ucH